baber/WOPTO huggingface dataset:
Patent WO-2021081585-A1 (WO)
Title: Procédés de dépôt d'oxydes conducteurs transparents
Inventor: KALANTAR-ZADEH KOUROSH
IPC: C23C4/11
Filed: 2020-10-29
Abstract: La présente invention concerne des matériaux d'oxyde conducteur transparent (TCO) destinés à être utilisés dans des dispositifs électroniques ou optoélectroniques et leurs procédés de fabrication. En particulier, l'invention concerne des matériaux d'oxyde d'indium-étain (ITO), qui peuvent être utilisés dans des applications comprenant les fenêtres intelligentes telles que les fenêtres à faible émissivité et les fenêtres électrochromes, la plasmonique, les dispositifs de biodétection à laboratoire sur puce, les affichages électroniques tels que les écrans à cristaux liquides et les écrans tactiles ; et des dispositifs optoélectroniques tels que des diodes électroluminescentes et des cellules solaires.
Patent AU-2020201143-A1 (AU)
Title: Metered and active sprayer devices with aerosol functionality ("FLAIROSOL II")
Inventor: MAAS WILHELMUS JOHANNES JOSEPH
IPC: B65D83/14
Filed: 2020-02-18
Abstract: In exemplary embodiments of the present invention, "Flairosol" dispensing devices can be provided. Such devices utilize a combination of Flair@ technology, pre compression valves and aerosol like pressurization of the dispensed liquid. Such a dispensing device has, for example, a main body comprising a pressure chamber, the latter being provided with a pressure piston and a pressure spring. The device further has a piston and a piston chamber which draws liquid from a container, for example, the inner container of a Flair@ bottle, and fills the pressure chamber with that liquid as a user operates a trigger in various compression and release strokes. The piston chamber has both an inlet valve and an outlet valve, which serve to prevent backflow. Liquid exiting the piston chamber under pressure (supplied by a user's pumping the trigger) enters a central vertical channel which is in fluid communication with both the pressure chamber (above the pressure piston) and a dome valve provided near the outlet channel at the top of the dispensing head. The dome valve has a preset pressure, such that once exceeded by the liquid, opens and allows for a spray. If the liquid pressure drops below such preset pressure the dome valve closes off the outlet channel, which serves to regulate the strength of the flow and preclude leakage. Alternatively, in an activated embodiment, for example, once the liquid is sufficiently pressurized, it can be dispensed by a user allowing the dome valve to open by pressing on an activation button that removes a dome lock.
Patent AU-2020204027-A1 (AU)
Title: Combination therapy
Inventor: HAO HUAIXIANG
IPC: A61K31/198
Filed: 2020-06-17
Abstract: The present disclosure relates to pharmaceutical products comprising a combination of 
(i) a MET inhibitor which is INC280 or a pharmaceutically acceptable salt or hydrate thereof and 
(ii) an EGFR inhibitor which is an monoclonal antibody such as cetuximab or panitumumab, 
which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical 
formulations, uses, methods, processes, commercial packages and related embodiments.
Patent AU-2020204672-A1 (AU)
Title: Subsea connection of pipeline sections
Inventor: MOHAN KARTHIK
IPC: F16L1/16
Filed: 2020-01-02
Abstract: A method of assembling a pipeline at a seabed location comprises landing a connection tool (10) on the seabed over a free end portion of a first pipeline section (12) already placed on the seabed. The connection tool is locked to the free end portion of the first pipeline section, a lower end of a second pipeline section (26) is connected to the connection tool via an initiation line (68). While applying tension to the initiation line against reaction force of the connection tool, at least a lower end portion of the second pipeline section is landed on the seabed with the lower end facing a free end of the first pipeline section. The lower end of the second pipeline section is then pulled into mechanical engagement with the free end of the first pipeline section.
Patent AU-2020209821-A1 (AU)
Title: Left ventricular volume and cardiac output estimation using machine learning model
Inventor: EL KATERJI AHMAD
IPC: A61B5/0215
Filed: 2020-01-15
Abstract: Methods and systems are disclosed for creating and using a neural network model to estimate a cardiac parameter of a patient, and using the estimated parameter in providing blood pump support to improve patient cardiac performance and heart health. Particular adaptations include adjusting blood pump parameters and determining whether and how to increase or decrease support, or wean the patient from the blood pump altogether. The model is created based on neural network processing of data from a first patient set and includes measured hemodynamic and pump parameters compared to a cardiac parameter measured
Patent AU-2020209991-A1 (AU)
Title: Formulations
Inventor: JOHNSON ANDY
IPC: A61K9/00
Filed: 2020-01-16
Abstract: The present invention relates to a pharmaceutical formulation comprising (i) a therapeutically effective amount of a bispecific protein comprising a soluble T cell receptor (TCR) and an scFV; and (ii) a surfactant. The w/w ratio of surfactant to protein is in the range of 0.75:1 to 1.5:1. The formulation may further comprise a bulking agent and/or a stabiliser. A further pharmaceutical formulation comprises (i) a therapeutically effective amount of a bispecific protein comprising a soluble T cell receptor (TCR) and an scFV; (ii) a bulking agent; and (iii) a stabiliser. The w/w ratio of stabiliser to bulking agent may be greater than 1:1.
Patent AU-2020226138-A1 (AU)
Title: Air filter device
Inventor: GULLIKSEN MORTEN
IPC: B01D45/00
Filed: 2020-02-21
Abstract: Air filter device comprising: one or more pleated air filters where the pleated air filters are cylindrical and designed according to the relation Gu=f
Patent AU-2020227074-A1 (AU)
Title: Providing a remote keyboard service
Inventor: SANCIANGCO ALEXANDER D
IPC: H04M1/72412
Filed: 2020-09-03
Abstract: The systems described herein provide a remote keyboard service for a media device on a 
computing device without having to invoke an application or unlock the computing 
device. The computing device can receive a message indicating that a text input field on 
the other device is selected and present a notification to the user prompting the user to 
invoke the virtual keyboard on the computing device to provide text input to the selected 
text input field. The computing device can receive user input selecting the notification 
and present a virtual keyboard for providing text input to the other device. The computing 
device can receive keyboard input from the user selecting characters and send the 
characters to the other device. The other device can then user the characters as text input 
to the selected text input field.
Patent AU-2020236735-A1 (AU)
Title: Gene therapy compositions and methods for treating parkinson's disease
Inventor: CORCORAN GAVIN
IPC: A61K38/00
Filed: 2020-03-10
Abstract: A method of improving motor function and reducing dyskinesia in a subject suffering from a neurodegenerative disease or a disease where endogenous dopamine levels are reduced in the subject comprising administering an effective amount of a viral vector comprising a nucleic acid construct comprising (i) a nucleotide sequence which encodes tyrosine hydroxylase (TH), (ii) a nucleotide sequence which encodes GTP-cyclohydrolase I (CH1), (iii) a nucleotide sequence which encodes Aromatic Amino Acid Dopa Decarboxylase (AADC), or any combination thereof to the subject.
Patent AU-2020242305-A1 (AU)
Title: Modified immune effector cells with increased resistance to cell death
Inventor: O'DWYER MICHAEL EAMON PETER
IPC: C12N5/10
Filed: 2020-03-20
Abstract: Immune effector cells and immune effector cell lines are modified to have increased resistance to TRAIL-induced cell death, by knockout of a TRAIL receptor or by linking a TRAIL receptor to an immune effector cell co-stimulatory domain, or both.
Patent AU-2020264808-A1 (AU)
Title: Methods of treating pruritus
Inventor: ROSEN YAEL
IPC: A61K31/4174
Filed: 2020-05-01
Abstract: The present disclosure related to methods of treating pruritus in a subject by topically administering detomidine, or a pharmaceutically acceptable salt thereof, to the subject.
Patent AU-2020266467-A1 (AU)
Title: A computer-enabled method, system and computer program for providing an intuitive user interface arranged to create a dynamic floor plan utilisable by an allocation algorithm to perform the task of allocating a space, furniture, equipment or service
Inventor: PETROULAS PETER
IPC: G06Q50/12
Filed: 2020-04-28
Abstract: In one embodiment, there is provided a computer-enabled method for creating a volumetric space/time framework of constraints for the dynamic allocation of a booking request to one or more spaces in a venue. In one embodiment, the invention is directed to a computer-enabled method including a user interface accessible via a remote device such as a Point of Sale device, wherein the Point of Sale device is arranged to receive an interactive, real-time, dynamic floor plan including allocated and unallocated bookings, table numbers, chair position numbers and interact with a restaurant operator or operators.
Patent AU-2020277258-A1 (AU)
Title: Motorized Luggage
Inventor: O'DONNELL KEVIN
IPC: A45C5/14
Filed: 2020-11-27
Abstract: This invention relates to motorized luggage comprising a frame enclosed in part by an outer shell, the 
frame defining an internal storage compartment, the internal storage compartment accessible through 
the outer shell by opening a first zippered portion of the outer shell, and wherein the top surface 
includes a seat; a front wheel positioned along the bottom surface of the frame; a retractable 
handlebar; first and second rear wheels; an electric motor mounted on the frame, and a retractable pull 
handle.
WO 2016/141091 PCT/US2016/020498 
1/6 
CI 
(Y(0 
< (N 
(0 k 
(0 
N )
Patent AU-2020281397-A1 (AU)
Title: Road simulation test rig
Inventor: DONG MINGMING
IPC: G01M17/007
Filed: 2020-05-29
Abstract: A road simulation test bench, which comprises a column supporting structure (10), a horizontal adjusting structure and a connecting plate (6), wherein the horizontal adjusting structure comprises an adjusting bracket (4), a linear guiding structure and a bearing plate (5), wherein the linear guiding structure is fixed onto the adjusting bracket (4), the linear guiding structure is used for supporting the bearing plate (5) and enabling the bearing plate (5) to move linearly, the first end of the adjusting bracket (4) is connected to the column supporting structure (10), and the connecting plate (6) is hinged to the lower side of the linear guiding structure. The road simulation test bench is stable in structure and flexible in size, and can adapt to road simulation test requirements of different types of chassis.
Patent AU-2020289319-A1 (AU)
Title: New formulations of microorganisms
Inventor: TAVARES ANDRE RUTE DA CONCEICAO
IPC: A01N25/28
Filed: 2020-05-27
Abstract: Polymer capsule comprising at least one polymer P1 and at least one microorganism M, where- in said polymer P1 has a solubility in water at 21°C of at least 1 g/l and wherein said polymer capsule has an average particle size d90 of below 100 µm, wherein said microorganism M is distributed throughout said capsule.
Patent AU-2020294200-A1 (AU)
Title: Drug delivery from hydrogels
Inventor: JARRETT PETER
IPC: A61F2/14
Filed: 2020-12-22
Abstract: Drug delivery involving hydrogels as used for various medical conditions, and 
includes hydrogels formed in an eye with extended drug release times. An embodiment of 
the invention is a method of delivering a therapeutic agent to a tissue comprising forming a 
5 hydrogel in situ in an eye with a therapeutic agent dispersed in the hydrogel, the agent having 
a low solubility in water. The agent may be essentially insoluble in water. The hydrogel may 
be made so that 50% to 100% w/w of the agent is released when the hydrogel is from 100% 
to 50% persistent, with the persistence being a measure of the dry weight of the hydrogel 
relative to an initial dry weight of the hydrogel.  
17175868_1 (GHMatters) P107307.AU.1
5 /13 
MAGNIFIED 
• • VIEW 
DISPERSED 
AGENT IN AGENT 
HYDROGEL* * * 
IN SITU FORMED DEPOT HYDROGEL 
RELEASE OF AGENT 
LOW CONCENTRATION OF AGENT 
RELEASE OF AGENT 
HIGH CONCENTRATION 
OFFAGENT 
RELEASE OF AGENT 
RELEASE OF AGENT 
ESSENTIALLY COMPLETE 
DEGRADATION DEGRADATION, 
WITH FINAL NO FINAL BURST 
BURSTOFAGENTRELEASE 
FIG. 6
Patent AU-2020308632-A1 (AU)
Title: Plant for filling and closing cans under hygienic conditions
Inventor: KUNZMANN ANDREAS
IPC: B67C3/22
Filed: 2020-06-25
Abstract: The invention relates to a plant (1) for filling and closing cans (2) under hygienic conditions, comprising a hygienic compartment (3), a lid applying device (7) and an inlet (30) for a filling material. The lid applying device (7) is arranged in the hygienic compartment (3) and the inlet (30) is formed on the hygienic compartment (3). When used as intended, one or more cans (2) can be assigned to the hygienic compartment (3) and the hygienic compartment (3) can be moved together with the can(s) (2) in the system (1).
Patent AU-2020313858-A1 (AU)
Title: Systems and methods for delivering therapy using an auricular stimulation device
Inventor: KHODAPARAST NAVID
IPC: A61N1/05
Filed: 2020-06-24
Abstract: Systems and methods for delivering therapy to a patient utilize transcutaneous stimulation of neural structures in a region of an ear of a patient delivered by an auricular stimulation device having an in-ear component with a first electrode disposed in a patient's ear and an earpiece component with a second electrode placed around the auricle. A pulse generator may control delivery of therapy by delivering both a first series of stimulation pulses to the first electrode for stimulating a first neural structure(s) and a second series of stimulation pulses to the second electrode for stimulating second neural structure(s). The first and second electrodes are in non-piercing contact with tissue on and/or surrounding the ear.
Patent AU-2020318422-A1 (AU)
Title: Method for the production of an enzymatic composition comprising a recombinant endopeptidase
Inventor: TARAVELLA ANNA
IPC: A61K38/48
Filed: 2020-07-08
Abstract: The present invention is directed to a method for manufacturing an enzyme preparation, comprising at least one recombinant Actinoallomurus endopeptidase with glutenase activity, at high yields and suitable for human use. The invention is further directed to a recombinant expression vector for expressing the recombinant endopeptidase(s) of interest, and to a S. lividans host cell comprising said vector. Moreover, the present invention is directed the enzyme preparation obtained by said method, to formulations of the same and to clinical uses thereof.
Patent AU-2020321718-A1 (AU)
Title: Components of open liquid drug transfer systems and a robotic system employing them
Inventor: KRIHELI MARINO
IPC: A61J1/20
Filed: 2020-07-27
Abstract: Presented herein are a robotic system that is configured for compounding and preparation of medications comprising non-hazardous drugs and a vented drug vial adapter. The robotic system comprises: a laminar flow cabinet; and at least one robotic arm. The vented drug vial adapter is designed to connect a drug vial to another component of a drug transfer system. The adapter comprises a hydrophobic filter that prevents passage of liquid while allowing air to pass through it and a vent hole to the atmosphere. The vent hole is located above the filter thereby allowing equalization of the internal pressure while preventing the drug from contaminating the atmosphere.
Patent AU-2020328254-A1 (AU)
Title: System and method for patterning flow cell substrates
Inventor: MODIANO STEVEN
IPC: C12Q1/6874
Filed: 2020-08-10
Abstract: A method for patterning flow cell substrates using photo-initiated chemical reactions that includes fabricating a planar waveguide flow cell by forming a layer of light coupling gratings on a glass substrate layer; depositing a core layer on the layer of light coupling gratings; depositing a cladding layer on the core layer; and forming nano wells in the cladding layer; silanizing the cladding layer; coating the silanized cladding layer and nano wells with a first group of reactants; introducing a second group of reactants into the nano wells, wherein the second group of reactants includes a target reactant and a light-sensitive photoinitiator system; coupling a light source to the light coupling gratings and directing light internally within the planar waveguide flow cell for photo-initiating a chemical reaction between the first and second groups of reactants, wherein the photo-initiated chemical reaction covalently binds the target reactant to only the bottom portion of each nanowell.
Patent AU-2020342807-A1 (AU)
Title: Adhesive tamper evident label
Inventor: MCDONAGH GARETH JAMES
IPC: G09F21/04
Filed: 2020-09-01
Abstract: The present invention provides an adhesive tamper evident vehicle registration label (1) or an adhesive tamper evident label support. The adhesive tamper evident vehicle registration label comprises a frangible layer (6) of a label comprising an upper surface (3) and an opposed lower surface (5), in which the frangible layer comprises a plurality of layer portions located adjacent to each other and separable from each other by at least one line of weakness (7) extending between the upper and lower surfaces thereof. The adhesive tamper evident vehicle registration label or the adhesive tamper evident label support further comprise an adhesive layer (2) located in use on the lower surface of the frangible layer or frangible support layer and configured to adhere the frangible layer or frangible support layer to a contact surface. The frangible layer of the adhesive tamper evident vehicle registration label or frangible support layer of the adhesive tamper evident label support is moveable between a first untampered position in which the layer portions or support layer portions provide a continuous surface extending across the upper surface thereof, and a second tampered position in which at least a pair of adjacent layer portions or support layer portions are separated from each other along the corresponding at least one opening and/or line of weakness.
Patent AU-2020356896-A1 (AU)
Title: Inhibitor of cell proliferation in obinutuzumab resistant CD20-positive cancer, and medicinal composition, medicine, production, method for inhibiting cell proliferation, therapeutic method, type II anti-CD20 antibody, compounds, combination of same, enhancer and inducer, each relating thereto
Inventor: FUJIMURA TAKAAKI
IPC: A61K31/704
Filed: 2020-09-18
Abstract: Among CD20-positive cancers, some develop a resistance to obinutuzumab and some reappear after being treated with the use of obinutuzumab.　According to the present invention, against a CD20-positive cancer resistant to obinutuzumab or a CD20-positive cancer reappearing after being treated with the use of obinutuzumab, a type II anti-CD20 antibody is used together with at least one compound selected from the group consisting of prednisolone, doxorubicin, vincristine, salts thereof and prodrugs thereof. Among these compounds, prednisolone, doxorubicin, salts thereof and prodrugs thereof may be selected. Among these compounds, moreover, prednisolone, salts thereof and prodrugs thereof may be selected.
Patent AU-2020381168-A1 (AU)
Title: GPR52 modulator compounds
Inventor: BUCKNELL SARAH JOANNE
IPC: C07D471/04
Filed: 2020-11-09
Abstract: The disclosures herein relate to novel compounds of Formula (1): (1) and salts thereof, wherein R
Patent AU-2020408139-A1 (AU)
Title: Incretin analogs and uses thereof
Inventor: ABRAHAM MILATA MARY
IPC: C07K14/605
Filed: 2020-12-11
Abstract: Incretin analogs are provided that have activity at each of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide- 1 (GLP-1) and glucagon (GCG) receptors. The incretin analogs have structural features resulting in balanced activity and extended duration of action at each of these receptors. Methods also are provided for treating diseases such as type 2 diabetes mellitus, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and obesity.
Patent AU-2020409875-A1 (AU)
Title: Production of fructose from oligo-/ and/or polysaccharides
Inventor: PICK ANDRÉ
IPC: C12P19/18
Filed: 2020-12-21
Abstract: The present invention relates to a method for converting at least one oligo- and/or polysaccharide into fructose comprising the steps of: a) adding to a composition comprising water, phosphate and at least one oligo- and/or polysaccharide at least four enzymes, and b) subsequently enzymatically converting the at least one oligo- and/or polysaccharide to fructose in the presence of the at least four enzymes, wherein in step a) at least one additional saccharide is added, whereby the at least one additional saccharide is selected from the group consisting of saccharides comprising 20 or less monosaccharide residues and/or combinations thereof; wherein in step a) the at least four enzymes, preferably at least five enzymes, are selected from the group consisting of transferases, phosphorylases, mutases, isomerases, hydrolases, phosphatases and combinations thereof; and wherein at least one enzyme in step a) is a phosphatase.
Patent AU-2020431122-A1 (AU)
Title: Reconstruction of obscured views of captured imagery using arbitrary captured inputs
Inventor: THURSTON III KIMBALL D
IPC: G06T5/00
Filed: 2020-09-30
Abstract: An imagery processing system obtains capture inputs from capture devices that might have capture parameters and characteristics that differ from those of a main imagery capture device. By normalizing outputs of those capture devices, potentially arbitrary capture devices could be used for reconstructing portions of a scene captured by the main imagery capture device when reconstructing a plate of the scene to replace an object in the scene with what the object obscured in the scene. Reconstruction could be of one main image, a stereo pair of images, or some number, N, of images where N>2.
Patent AU-2020451285-A1 (AU)
Title: Methods of treatment using ICAM-modulating agents
Inventor: DEISHER THERESA
IPC: A61K31/573
Filed: 2020-06-01
Abstract: This invention pertains to methods of treating cancer and lymphocyte mediated diseases using Intercellular Adhesion Molecule (ICAM)-modulating agents.
Patent WO-2021232111-A1 (WO)
Title: Water sanitisation device, system and method
Inventor: BRISCOE NICHOLAS JAMES
IPC: C25B1/26
Filed: 2021-05-21
Abstract: A method of sanitising a body of water including the steps of adding sodium chlorite and/or sodium chlorate to the body of water and converting the sodium chlorite and/or sodium chlorate to chlorine dioxide in an electrolysis cell which is in fluid communication with a water circulation system of the body of water, wherein chlorine is also added to the body of water.